Latest Period
Q2 2026
Security Snapshot
Humacyte, Inc. - Common Stock (HUMA) Institutional Ownership
CUSIP: 44486Q103
13F Institutional Holders and Ownership History from Q3 2021 to Q2 2026
Institutions Reporting
161
Shares (Excl. Options)
73,251,052
Price
$0.78
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- HUMA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 73,251,052
- Total 13F value
- $57,147,087
- Portfolio coverage rank
- 0%
- Share change
- +13,682,194
- Value change
- +$10,903,668
- Number of holders
- 161
- Shares outstanding
- 272,828,667
- SEC-reported price per share
- $0.62
- Insider filing price
- $0.62
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HUMA - Humacyte, Inc. - Common Stock is tracked under CUSIP 44486Q103.
- 161 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 157 to 161 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $35,736,274 to $57,147,087.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 161 institutions filings for Q2 2026.
Security key
44486Q103
Latest holder period
Q2 2026
13F holders
161
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
HUMA full holder history
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Humacyte, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 44486Q103:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
HUMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 4.7% | $16,367,453 | 12,787,073 | Davidson Kempner Capital Management LP | 12 Jun 2026 | |||
| BlackRock, Inc. | 1.5% | $3,193,732 | 4,092,430 | BlackRock, Inc. | 30 Jun 2026 |
As of 30 Jun 2026, 161 institutional investors reported holding 73,251,052 shares of Humacyte, Inc. - Common Stock (HUMA). This represents 27% of the company’s total 272,828,667 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.7% | 10,107,679 | +41% | 0% | $7,883,990 |
| ANTIPODES PARTNERS Ltd | 3.7% | 10,103,647 | +77% | 0.14% | $7,884,886 |
| Alyeska Investment Group, L.P. | 2.2% | 6,022,925 | 0.01% | $4,700,291 | |
| Davidson Kempner Capital Management LP | 1.8% | 5,000,000 | 0.06% | $3,902,000 | |
| BlackRock, Inc. | 1.8% | 4,839,929 | -61% | 0% | $3,777,079 |
| GREAT POINT PARTNERS LLC | 1.4% | 3,750,000 | 0% | 0.69% | $2,926,500 |
| UBS Group AG | 1% | 2,843,493 | +2.2% | 0% | $2,217,924 |
| AQR CAPITAL MANAGEMENT LLC | 0.95% | 2,597,134 | +35% | 0% | $2,026,801 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.8% | 2,185,225 | -40% | 0% | $1,706,048 |
| MILLENNIUM MANAGEMENT LLC | 0.7% | 1,909,049 | +1665% | 0% | $1,489,822 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.62% | 1,699,243 | +61% | 0% | $1,326,089 |
| CITADEL ADVISORS LLC | 0.53% | 1,443,376 | 0% | $1,126,411 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.5% | 1,353,515 | +4.8% | 0% | $1,056,283 |
| VANGUARD FIDUCIARY TRUST CO | 0.43% | 1,181,276 | +17% | 0% | $921,395 |
| HRT FINANCIAL LP | 0.4% | 1,089,508 | 0% | $850,000 | |
| LPL Financial LLC | 0.38% | 1,025,535 | +19% | 0% | $800,327 |
| GSA CAPITAL PARTNERS LLP | 0.37% | 1,005,709 | +303% | 0.05% | $785,000 |
| Private Advisor Group, LLC | 0.35% | 965,091 | +16% | 0% | $753,156 |
| STATE STREET CORP | 0.31% | 842,537 | -72% | 0% | $657,516 |
| HBK INVESTMENTS L P | 0.29% | 790,000 | 0.01% | $616,516 | |
| WEALTH EFFECTS LLC | 0.25% | 693,920 | +239% | 0.15% | $541,535 |
| Lion Point Capital, LP | 0.24% | 650,000 | 0% | 2.4% | $507,260 |
| LuminArx Capital Management LP | 0.24% | 650,000 | 0% | 0.32% | $507,260 |
| GOLDMAN SACHS GROUP INC | 0.21% | 586,524 | -13% | 0% | $457,723 |
| BANK OF AMERICA CORP /DE/ | 0.21% | 578,592 | +46% | 0% | $451,303 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q2 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 73,251,052 | $57,147,087 | +$10,903,668 | $0.78 | 161 |
| 2026 Q1 | 58,879,310 | $35,736,274 | +$739,029 | $0.61 | 157 |
| 2025 Q4 | 55,385,756 | $53,205,316 | +$7,815,206 | $0.96 | 146 |
| 2025 Q3 | 45,803,224 | $79,706,858 | -$20,549,961 | $1.74 | 138 |
| 2025 Q2 | 56,964,566 | $119,040,607 | -$1,729,485 | $2.09 | 155 |
| 2025 Q1 | 60,715,449 | $103,532,553 | +$24,167,009 | $1.70 | 162 |
| 2024 Q4 | 42,106,165 | $212,715,890 | +$30,515,138 | $5.05 | 161 |
| 2024 Q3 | 35,792,230 | $194,660,626 | +$23,757,191 | $5.44 | 143 |
| 2024 Q2 | 31,200,014 | $149,783,918 | +$47,689,218 | $4.80 | 120 |
| 2024 Q1 | 23,275,197 | $72,382,833 | +$17,071,734 | $3.11 | 95 |
| 2023 Q4 | 17,820,871 | $50,656,070 | +$3,312,296 | $2.84 | 87 |
| 2023 Q3 | 16,610,977 | $48,671,458 | +$5,715,520 | $2.93 | 83 |
| 2023 Q2 | 14,729,897 | $42,225,781 | +$7,517,496 | $2.86 | 75 |
| 2023 Q1 | 12,062,725 | $37,417,372 | +$154,698 | $3.09 | 68 |
| 2022 Q4 | 11,918,522 | $25,143,027 | -$3,006,763 | $2.11 | 71 |
| 2022 Q3 | 11,840,854 | $38,602,556 | -$5,136,200 | $3.26 | 68 |
| 2022 Q2 | 13,437,579 | $43,130,190 | +$8,049,232 | $3.21 | 75 |
| 2022 Q1 | 10,487,756 | $73,993,016 | +$6,152,869 | $7.06 | 69 |
| 2021 Q4 | 9,522,696 | $69,016,600 | +$7,310,797 | $7.25 | 58 |
| 2021 Q3 | 4,907,194 | $56,957,000 | +$56,946,000 | $11.61 | 31 |